These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37898039)
1. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters. Ahuja S; Khan AA; Zaheer S; Ranga S Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039 [TBL] [Abstract][Full Text] [Related]
2. Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion. Noda Y; Ishida M; Ueno Y; Fujisawa T; Iwai H; Tsuta K BMC Cancer; 2022 Apr; 22(1):402. PubMed ID: 35418058 [TBL] [Abstract][Full Text] [Related]
3. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice. Almangush A; Leivo I; Mäkitie AA Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615 [No Abstract] [Full Text] [Related]
4. Tumor infiltrating lymphocytes in head and neck squamous cell carcinoma - Evaluation and clinical impact. Dasgupta S; Chakrabarti S; Deb AR J Cancer Res Ther; 2022; 18(1):49-54. PubMed ID: 35381761 [TBL] [Abstract][Full Text] [Related]
5. Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Suzuki H; Kawasaki Y; Miura M; Hatakeyama H; Shina K; Suzuki S; Yamada T; Suzuki M; Ito A; Omori Y Asian Pac J Cancer Prev; 2022 Apr; 23(4):1271-1278. PubMed ID: 35485685 [TBL] [Abstract][Full Text] [Related]
6. Role Of Cd8+ Tumour-Infiltrating Lymphocytes In Predicting Regional Lymph Node Metastasis In Lip And Oral Cavity Squamous Cell Carcinoma. Sukhera ZA; Zafar N; Ara N; Muneer S; Haroon A; Saeed Z J Ayub Med Coll Abbottabad; 2023; 35(2):288-293. PubMed ID: 37422823 [TBL] [Abstract][Full Text] [Related]
7. Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method. De Keukeleire SJ; Vermassen T; De Meulenaere A; Deron P; Huvenne W; Duprez F; Creytens D; Van Dorpe J; Rottey S; Ferdinande L Pathology; 2021 Dec; 53(7):836-843. PubMed ID: 34217516 [TBL] [Abstract][Full Text] [Related]
8. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143 [TBL] [Abstract][Full Text] [Related]
9. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group. Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer. Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors. Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208 [TBL] [Abstract][Full Text] [Related]
13. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma. Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590 [TBL] [Abstract][Full Text] [Related]
14. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis. Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755 [TBL] [Abstract][Full Text] [Related]
16. Density and location of CD3 Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989 [TBL] [Abstract][Full Text] [Related]
17. A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma. Shaban M; Khurram SA; Fraz MM; Alsubaie N; Masood I; Mushtaq S; Hassan M; Loya A; Rajpoot NM Sci Rep; 2019 Sep; 9(1):13341. PubMed ID: 31527658 [TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of Tumor Infiltrating Lymphocytes(TILS) CD4 + and CD8 + in Oral Squamous Cell Carcinoma (OSCC) in Correlations with Clinicopathological Characteristics and Prognosis. Wahbi HS; Manadili A Asian Pac J Cancer Prev; 2022 Dec; 23(12):4177-4183. PubMed ID: 36580000 [TBL] [Abstract][Full Text] [Related]
19. TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)? De Meulenaere A; Vermassen T; Aspeslagh S; Vandecasteele K; Rottey S; Ferdinande L Head Neck Pathol; 2017 Sep; 11(3):354-363. PubMed ID: 28032290 [TBL] [Abstract][Full Text] [Related]
20. Expression of immune response biomarkers (PD‑L1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas. Pflumio C; Thomas J; Salleron J; Faivre JC; Borel C; Dolivet G; Sastre-Garau X; Geoffrois L Oncol Rep; 2021 Mar; 45(3):1273-1283. PubMed ID: 33432367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]